Posted inGenetics
Malaria Transmission Blocked by One-Amino-Acid Mosquito CRISPR Edit
As mosquitoes evolve resistance to insecticides and malaria parasites outsmart frontline drugs, public health tools are losing ground in the…
Posted inGenetics
Biological Clock Temperature Cycles Explained by Waveform Distortion
Most biochemical reactions accelerate as temperature increases, but our daily circadian rhythms, which are underlain by gene regulatory and biochemical…
Posted inResearch
Roche’s Flatiron Health triples cancer network size across UK, Germany and Japan
Roche’s Flatiron Health is celebrating a milestone. Over the last year, the company has tripled the size of its international…
Posted inMedical Technology
FDA spotlights infusion issue with Baxter large-volume pumps after 2 deaths
The FDA is spotlighting a new medical device correction effort at Baxter over its large-volume Novum IQ infusion pump, following…
Posted inMedical Technology
Boston Scientific bumps up financial forecasts amid medsurg, cardiology gains
Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across multiple medtech…
Posted inBiotechnology
Genentech eliminates 87 jobs in another round of South San Francisco layoffs
Genentech has executed another round of layoffs, eliminating 87 positions at its headquarters in South San Francisco. The dismissals, which…
Posted inBiotechnology
With $550M on the line, Arrowhead reassures investors about pact with troubled Sarepta
Arrowhead Pharmaceuticals has moved to reassure Wall Street about its deal with Sarepta Therapeutics, telling investors it expects its troubled R&D…
Posted inBiotechnology
FDA opens national priority fast track, offering 2-month reviews to onshoring and affordability projects
The FDA has begun accepting applications for a priority pathway designed to slash review times to between one and two months,…
Posted inGenetics
AstraZeneca Commits $50B More to U.S. Manufacturing, R&D Projects
AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of manufacturing and…
Posted inBiotechnology
Abivax aces pair of phase 3 ulcerative colitis trials as end of cash runway looms
After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its…